A comprehensive view of Eye Care / Vision Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
Australia Patent: JOHNSON & JOHNSON VISION CARE Files Application for 'SYSTEMS AND METHODS FOR PREDICTING MYOPIA RISK'
Published:
April 19, 2024
by Australian Government
|
US Patent Issued to Johnson & Johnson Surgical Vision on April 16 for "Learning auto phaco phacoemulsification mode for ophthalmic surgery" (California Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
US Patent Issued to Johnson & Johnson Vision Care on April 16 for "Photostable mimics of macular pigment" (Florida Inventor)
Published:
April 17, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: JOHNSON & JOHNSON SURGICAL VISION, INC. FILES APPLICATION FOR "REDUCING INTRAOCULAR PRESSURE (IOP) FLUCTUATIONS DURING PHACOEMULSIFICATION"
Published:
April 15, 2024
by U.S. Fed News
|
US Dept. of Justice files complaint alleging fraudulent drug pricing practices by Regeneron for its ophthalmology drug Eylea that cost Medicare hundreds of millions of dollars
Published:
April 12, 2024
by Zack's Commentary
|
Ask us about our Bioeconomy market view